SCHEMBL24258354

SCHEMBL24258354

C=Cc1cc(F)ccn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25402476 0.77 — —
SCHEMBL11999814 0.77 — —
SCHEMBL6982115 0.77 — —
SCHEMBL29503544 0.74 ALDH1A1 (0.39) —
SCHEMBL1655827 0.74 ALDH1A1 (0.39) —
SCHEMBL16289411 0.74 — —
SCHEMBL1282140 0.73 — —
SCHEMBL13117471 0.73 — —
SCHEMBL5170675 0.73 — —
SCHEMBL29025153 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024183806-A1 COMPOUNDS, PREPARATION METHODS AND USES THEREOF InventisBio Co., Ltd. (CN) 2024-09-12 — — WO disclosed
EP-3177612-B1 OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED DERIVATIVES OF PYRIMIDINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGIC AND AUTOIMMUNE DISEASES NUEVOLUTION AS (DK) 2022-02-23 — — EP disclosed
Send feedback